U.S. GNC Holdings raises $150 mln investment from China’s Harbin Pharma

02/14/2019 9:02:00 AM (GMT)

U.S.-based health and wellness retailing company GNC Holdings Inc. has completed with $150 million in an investment round.

The investment, which came from Chinese drugmaker Harbin Pharmaceutical Group Co. Ltd., is part of its previously announced $300 million strategic investment.

As a result of the infusion, GNC Holdings also announced the formation of China second, a retail-focused joint venture with Hayao.

The second JV is expected to be closed in the second or third quarter of 2019, subject to certain routine regulatory and legal requirements.

Harbin Pharmaceutical Group Holding Co.

All success stories are prepared by Investsize editors which is selecting elite and remarkable information from press releases and anonymous news sources.There is no charge applied for any success stories which is published . Those published success stories are not investment advices and doesnt offer recommendations Alternate Text